Study Overview:

An in vitro assay known as ProDigest was conducted in a controlled laboratory setting to evaluate the impact of Monch Monch® on nutrient absorption and the production of short-chain fatty acids (SCFAs).

Key Findings:

• Reduced Absorption of Simple Carbohydrates: Monch Monch® decreased the absorption of glucose, fructose, sucrose, and simple starches by up to 38%, reducing carbohydrate caloric intake.
• Increased Production of SCFAs: There was a 60% increase in the production of SCFAs, which are beneficial for gut health.

These results suggest that Monch Monch® may help optimize nutrient absorption and promote the production of beneficial SCFAs in the gut.

Learn More: ProDigest Official Website

Study Overview:

A double-blind, placebo-controlled clinical trial was conducted at the Royal Melbourne Institute of Technology in Australia.

The study involved 74 overweight participants without glucose intolerance, aiming to assess the real-world effects of Monch Monch®.

Participants consumed one teaspoon of Monch Monch® with their breakfast and dinner daily for four weeks.

Key Findings:

• Body Composition Improvements: Participants experienced decreased total and visceral fat mass and increased lean body mass.
• Blood Pressure Reduction: The study observed decreased systolic and diastolic blood pressure among participants.

Compared to the placebo group, participants experienced significant improvements in body composition and cardiovascular markers, suggesting that Monch Monch® may positively influence overall health through diet change.

Study Overview:

A double-blind, placebo-controlled clinical trial was conducted by Vedic Life Sciences in India.

The study involved 64 individuals with mild obesity and glucose intolerance (excluding those with type 2 diabetes), aiming to assess the effects of Monch Monch® on metabolic and gastrointestinal parameters.

Participants consumed one teaspoon of Monch Monch® with their breakfast and dinner daily for three weeks.

Key Findings:

• Metabolic Improvements: Participants showed reduced post-meal blood glucose peaks, decreased post-meal serum insulin levels, lowered insulin resistance (measured by HOMA-IR), and increased butyrate levels—a metabolite known to enhance GLP-1 production.
• Appetite and Digestive Comfort: The study reported decreased food cravings, reduced focus on food ("food noise"), and relief from abdominal discomfort, including reductions in pain, bloating, and nausea.

These findings indicate that Monch Monch® may assist in glucose management and improve gastrointestinal well-being in individuals with mild obesity and glucose intolerance.

Study Overview:

An observational study was conducted with 40 participants to examine the effect of Monch Monch® on glycemic response when consuming a candy bar.

Key Findings:

• Glycemic Control: The data showed a reduction of peak blood glucose levels by 20 mg/dL, a faster return to baseline glucose levels after consumption, and no instances of reactive hypoglycemia observed.

The results suggest that Monch Monch® may help modulate glycemic response, potentially improving blood sugar control even when consuming high-sugar foods.